Pfizer expects $54 billion in 2022 sales on Covid vaccine and treatment pill


Pfizer expects to sell $32 billion of its Covid-19 shots and $22 billion of its antiviral coronavirus treatment pill Paxlovid.

Source

Leave a Reply

Your email address will not be published.